Johnson & Johnson Thrives Amid Healthcare Surge, Robust Earnings, and Investor Optimism

# Johnson & Johnson Stock Analysis: Trading Near Annual High on Strong Earnings & Dividend Growth Discover why Johnson & Johnson (JNJ) shares are approaching their yearly high of $177.57 in our latest podcast episode. We break down the healthcare giant's impressive 5.8% revenue growth to $23.7B and adjusted EPS of $2.77 that's driving renewed investor confidence. Learn why trading volume has surged past 2 million pre-market shares, exceeding the daily average of 8 million, and what this signals for investors. Our analysis covers JNJ's attractive dividend yield of nearly 3%, recent analyst ratings from major firms like Morgan Stanley and UBS, and what insider selling activity might really indicate about the company's future. Whether you're focused on healthcare sector investments, dividend income strategies, or blue-chip stocks with defensive qualities, this episode provides essential insights into one of the market's most stable performers and why analysts maintain a "moderate buy" consensus despite varying price targets. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.